March 29, 2021
CHMP recommends Novo Nordisks’s Saxenda for the treatment of obesity in adolescents
The Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) has recommended that the use…
Pharmaceuticals, Biotechnology and Life Sciences
The Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) has recommended that the use…
People treated with Saxenda for weight management lost an average of 8.1 kg after six months in a real-world clinical…